Top Searches
- News
- India News
- 'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials'
'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials'
NEW DELHI: Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources.
The Hyderabad-based firm had earlier submitted the trial data to the Subject Expert Committee (SEC) of the Indian drug regulator.
The expert panel has approved the trial data. The trials were conducted on 25,800 subjects, as per reports.
Bharat Biotech's indigenously developed Covaxin is one of the three vaccines currently in use in India. Covishield, developed by AstraZeneca and manufactured locally by Serum Institute of India and Russia's Sputnik V are the other two vaccines being administered
The company has developed the vaccine in association with the Indian Council of Medical Research (ICMR).
Watch Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy
The Hyderabad-based firm had earlier submitted the trial data to the Subject Expert Committee (SEC) of the Indian drug regulator.
The expert panel has approved the trial data. The trials were conducted on 25,800 subjects, as per reports.
Bharat Biotech's indigenously developed Covaxin is one of the three vaccines currently in use in India. Covishield, developed by AstraZeneca and manufactured locally by Serum Institute of India and Russia's Sputnik V are the other two vaccines being administered
The company has developed the vaccine in association with the Indian Council of Medical Research (ICMR).
Watch Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy
FacebookTwitterLinkedinEMail
Start a Conversation
end of article
Quick Links
Coronavirus in MumbaiFarm bill 2020Farmers protestCoronavirus in DelhiCoronavirus in BangaloreCoronavirus symptomsCoronavirus in IndiaWest Bengal elections 2021Coronavirus NewsSolar EclipseNPRWhat is NRCCAB BillCAB and NRCAssam election 2021Podcast newsLok SabhaTamil Nadu Election 2021CongressBJP newsKerala Elections 2021Indian ArmyISRO newsSupreme Court
Popular Categories
Hot on the Web
Top Trends
Corona cases in IndiaCovid vaccineIND vs NZ WTC FinalCoronavirus India update liveCBSE Class 12Karnataka unlock newsLive Cricket ScoreDelhi Covid newsJammu Kashmir newsSouthampton weatherJet AirwaysTamil Nadu lockdown newsCovid vaccine certificate downloadPoovachal KhadarUS News HeadlinesCovid vaccine registrationHoroscope todayLatest News
Trending Topics
Living and entertainment
Copyright © 2021 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service